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Abstract
After World War II, the use of artificially produced radionuclides in medicine began and 
led to great success in the fight against cancer and other diseases. However, the highly 
radioactive compounds had to be handled with great care to protect patients and hos-
pital personnel from radiation. The survey of these radionuclides in the environment 
followed some years later. In Switzerland, double-tracked monitoring programs were 
started. On the emission side, hospitals and industries handling radiopharmaceuticals 
had to report their consummation of radionuclides yearly. A monitoring program of their 
waste waters and solid wastes was also started. On the immission side, the remaining 
radioactive wastes, which were released to the environment, had to be surveyed. Overall, 
only a few violations of the limits for radiopharmaceuticals were observed over the last 
30 years in Switzerland. Nevertheless, the monitoring of radioactivity in the environment 
remains an important task as long as radionuclides are used in medicine.
Keywords: radiopharmaceuticals, y-90, Lu-177, I-131, sewage sludge, sewer sludge, 
suspended matter
1. Introduction
Radiopharmaceuticals were first synthesised back in 1933. In Paris, Irène and Frédéric Joliot-
Curie produced the first synthetic radionuclide by irradiating aluminium foil with alpha par-
ticles. They obtained a radioactive phosphor nuclide (30P). The irradiation of boron resulted 
in a radioactive nitrogen nuclide [1]. Soon after their discovery of synthetic radionuclides, 
first applications were published (e.g., studies of metabolism with radioactive tracers and 
the use of radionuclides in diagnosis and therapy started). After World War II, the nuclear 
pharmacy industry started in USA. In the 1960s, a group of scientists founded the “radiologi-
cal chemistry” at the University of Basel. Their focus was on the synthesis and applications of 
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protein-bound radionuclides. They were the first to develop DOTATOC1-bound 111In and 90Y 
and apply them with success against tumours.
1.1. Application of radiopharmaceuticals
i. Today, a broad range of radiopharmaceuticals are used for diagnostics and the fight 
against cancer and other diseases. Radionuclides are either used in their pure form (e.g., 
223RaCl
2
) or bound on a carrier. For diagnosis, they are used in scintigraphy, positron emis-
sion tomography (PET), single photon emission computed tomography (SPECT) and oth-
ers. Specific radionuclides that are in use include the following:99mTc (technetium-99m), 
which is used for the scintigraphy of the skeleton, heart, lung, brain, liver, kidney, marrow 
etc. It is also used in techniques, such as myocardia- and parotid scintigraphy.
ii. For the detection of neuroendocrine tumours, 111In (indium-111) and 68Ga (gallium-68) 
can be used.
iii. For the diagnosis of prostate tumours, brain tumours and metastases in bones, 18F (fluo-
rine-18) is commonly used as the radionuclide in scintigraphy.
Specific radionuclides used in therapeutical applications include the following:
131I (iodine-131), a thyreostatica which is administered in the form of swallowable 131I–cap-
sules, is used to treat diseases of the thyrea (hyperthyroidism and Basedow’s disease). In 
Switzerland, 200 MBq may be applied for ambulatory treated patients. For higher activities, 
patients have to stay at specially isolated rooms, until the required dose becomes less than 
5 μSv/h at a distance of 1 m. 131I is also applied bound with MIBG (metaiodobenzyl-guanidine).
i. 90Y (yttrium-90) and 177Lu (lutetium-177) are applied successfully against neuroendocrine 
tumours. These radionuclides are bound to DOTATOC, an octapeptide, which has a simi-
lar structure as the hormone somatostatin. 90Y is applied in selective, internal radiothera-
py (SIRT) bound on spherical polymer particles.
ii. 90Y–Zevalin is used against lymphoma.
iii. Other radionuclides, such as 90Y, 188Re (rhenium-188), 169Er (erbium-169), are applied for 
radiation synovectomy2.
iv. A recently available radionuclide is 223Ra (radium-223). In the form of radium dichloride, 
Xofigo, it can be used against prostate tumours that have spread to the skeleton. In Basel, 
it has been administered since 2013.
1.2. Use of radiopharmaceuticals in Basel and Switzerland
The Federal Office for Public Health, Radioprotection Section, publishes annually the con-
sumption of radionuclides and radiopharmaceuticals by industry and hospitals together 
with data from the radioactivity monitoring of the effluents of waste water treatment plants 
(WWTP) and other emission sources in Switzerland [2].
1DOTATOC: 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate coupled with an octapeptide.
2An application of radiopharmaceuticals to fight arthritis and arthrosis.
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Today, 33 Swiss hospitals use radionuclides. Twenty-three of these hospitals discharge their 
contaminated waste waters to WWTPs, which are connected to the Rhine/Aar River system. 
Table 1 lists the most used radionuclides in Switzerland and the percentage of their use in 
Basel compared to the whole Switzerland [3].
As can be observed, the Basel University Hospital is highly specialised in applications of 90Y 
and 177Lu. Only a few GBq of 177Lu are applied in hospital centres at Bern, St. Gallen, Lausanne 
and Zurich. 90Y is used in many hospitals, but in remarkably lower activities than in Basel. 
Figure 1 shows consumption of radionuclides of radionuclides over the last 18 years. The con-
sumption of 131I is almost stable between 300 and 500 GBq/year. 90Y shows a maximum in 2009 
(2500 GBq/year); its use has been reduced since 2009 to almost 1000 GBq/year. Applications of 
Switzerland Hospitals in Basel City Percentage of Basel City
131I ambulant appl. 25.2 0 0
131I hospitalised appl. 2.593 221 9
186Re 2.3 0.4 16
169Er 1.0 0 0
90Y 1.099 568 52
153Sm 4.0 0 0
177Lu 3.040 2.608 86
223Ra 4.1 0.2 3
Data from [2]. appl: applications for ambulatory or hospitalised patients; LE: exemption limit.
Table 1. Applied radionuclides in Switzerland 2016, in GBq.
Figure 1. Yearly consumed activities of radiopharmaceuticals at Basel hospitals since 1998.
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177Lu started in 2002 and started to rise over the years to 3000 GBq/year in 2016. In that year, 
the hospitals of Basel used overall 4.5 TBq activity. In Basel, more than 8000 persons per year 
were treated with radiopharmaceuticals for diagnosis and therapies against cancer and for 
other applications [4].
Waste water and other wastes of patients are collected in special stainless steel tanks, while 
the patients are hospitalised. Due to their short half-lives, the activity of the radionuclides 
declines very fast. Cooling time in the storage tanks is several weeks. Once a week, tanks are 
discharged into the waste net when the activity of the radionuclides falls below a specified 
activity level. This level is fixed in such a way that the limit values for rivers cannot be reached.
2. Legislation in Switzerland
Since 1991, in Switzerland, radionuclides are regulated by the Radioprotection Act (from 22 
March 1991) [5] and the Radioprotection Ordinance (RPO) (from 22 June 1994) [6]. In Annex 
Radionuclide Half-life decay LE
Bq/kg
Activity limit 
(Bq/kg)1
Activity load per 
month2
(kBq)
Limit value for surface 
water3
(Bq/kg)
18F 109.8 m β+ 200.000 2.000 20.000 4.000
44Sc 3.93 h β+, γ 30.000 300 3.000 600
67Ga 78.3 h γ 50.000 500 5.000 1.000
68Ga 68 m β+, γ 100.000 1.000 10.000 2.000
85Sr 65 d γ 20.000 200 2.000 400
90Y 64 h β− 4.000 40 400 80
99mTc 60.2 h γ 500.000 5′000 50.000 10.000
110mAg 249.9 d β−, γ 4.000 40 400 80
111In 2.83 d γ 30.000 300 3.000 600
131I 8.04 d β−, γ 500 5 50 10
133I 20.8 h β−, γ 2.000 20 200 40
153Sm 46.7 h β−, γ 10.000 100 1.000 200
169Er 9.3 d β−, γ 30.000 300 3.000 600
177Lu 6.71 d β−, γ 20.000 200 2.000 400
177mLu 160.9 d β−, γ 6.000 60 600 120
186Re 90.6 h β−, γ 7.000 70 700 140
188Re 17.0 h β−, γ 7.000 70 700 140
223Ra 11.4 α, γ 100 1 10 2
Source: Swiss Radioprotection Ordinance [6].
1About 1% of the exemption limit (LE).
2About 100 fold of LE for waste water.
3About 1/50 of LE for rivers and lakes.
Table 2. Limits for radionuclides used in medicine.
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2 of the RPO, solid and liquid wastes may not reach activities higher than a permitted limit 
(EL3). For higher activities, the material has to be treated as “radioactive” according to the 
Ordinance. For waste water, the activity limit is set to 1% of the EL of each radionuclide. 
Mixtures of radionuclides are considered as follows (summation rule):
  a 1  /  EL 1 +  a 2  /  EL 2 + … + A n  /  EL n  < 0.01 (1)
with axe: activity of radionuclide x, ELx: exemption limit of radionuclide x.
The sum in Eq. (1) has to be below 0.01; then, the activity of the waste water is under the limit 
value. Further, a specific discharge limit per month for treated and untreated waste water 
has to be fulfilled. A violation is present when both limits are overridden. The aim of these 
restrictions is to guarantee a limit value of 1/50 of EL for each radionuclide in rivers and lakes 
(according to Art.102. Par. 2 of the RPO). The Federal Office of Public Health uses the same 
limits for treated waste waters that are discharged to rivers and lakes (Table 2).
3. The waste treatment in Basel City
3.1. The waste water treatment: The municipal WWTP of Basel
The whole waste water of the city of Basel is treated at the WWTP Pro Rheno. In this plant, the 
waste water (A) is treated in three main steps (see Figure 2): First solids are taken out by a coarse 
screen (3). Yearly, 370 tonnes of solid wastes are extracted in that way and burnt at the incinera-
tion station KVA Basel (a) [7]. Then, the waste water runs through degritters (4). The filtered off 
solid materials are disposed at a nearby landfill site (b). The pre-cleaned waste water undergoes a 
preliminary cleaning with a primary clarification step (5). Then follows a biological treatment of 
3EL: exemption limit. The ingestion of 1 kg of a radionuclide with a specific activity of 1 EL yields a committed effective 
dose of 10 μSv [6].
Figure 2. Scheme of the municipal WWTP of the city of Basel, ProRheno (source: ProRheno AG (with the kind permission 
of ProRheno AG [7]). Details explained in the text.
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the waste water with activated sludge and oxygen, where most organic substances are degraded 
(7). The produced sewage sludge is isolated by sedimentation. At last, the waste water undergoes 
a secondary clarifying step (8). Over 90% of the organic carbon is degradable. Phosphates, which 
are the most important nutrient for algae, are eliminated by chemical precipitation. Nitrogen is 
not eliminated (e.g., by a nitrification/denitrification process). The so treated waste water is then 
released to the Rhine River below the city of Basel, near the border to Germany and France (B). 
The isolated sewage sludge is centrifuged (c, d). This thickened sludge is then burnt in fluidized 
bed furnaces (9). The ashes are disposed at a nearby landfill site (Figure 2).
A total of 270,000 inhabitants of Basel City and surrounding villages (several villages of France 
and Germany included) release their waste waters to the waste net of the city, which has a 
length of about 360 km. It ends at the WWTP in the north of the city. The WWTP treats 82,000 m3 
of waste water a day; 30 million m3 waste water a year, respectively. About 40% of the waste 
water originates from households (170 L of water are used per person per day). Special waste 
waters are discharged by the hospitals and industries. Waste waters from chemical industries 
in Basel are treated in a separate, independent WWTP, especially built for the treatment of 
chemical waste waters. For more details about the WWTP, visit the website of ProRheno [8].
3.2. The solid waste treatment at Basel: The municipal waste incineration plant of 
Basel
The waste incineration plant KVA Basel has a capacity of 230,000 tonnes/year for burning wastes 
from households and permitted wastes from industries (that means 103 tonnes a day) [9]. 
Only 29% of the wastes are from the city of Basel. About 54% of the wastes are delivered from 
the state of Basel-Campaign and other Swiss states. The German Landkreis Lörrach delivers 
another 17%. The wastes originate from about 700,000 persons. They are burnt in two oven lines, 
which produce 537 GWh/year of heating energy (the value for energy consumption is 76%). The 
fire gases are cleaned in several steps: dust is eliminated by electrofilters. Nitrogen oxides are 
neutralised with ammonia. To destroy toxic dioxins and furans, special catalysts are used. The 
pre-cleaned air then undergoes a wet scrubbing with water. This waste water is treated on site 
with the incinerator’s own treatment plant. The chemical quality of the cleaned water (about 
190 m3/d) satisfies the quality criteria for treated waste water and can therefore be discharged 
directly to the Rhine River. The ashes are cooled down with water and stored in bunkers. About 
43,800 tonnes of ashes are disposed of at a nearby landfill site. For more information, see [10].
4. Materials and methods
4.1. Swiss monitoring programme
Since 1956, environmental radioactivity has been continuously monitored in Switzerland. The 
motivation for the programme was the occurrence of the global fallout from bomb tests. Since 
1986, the Federal Office of Public Health (BAG) is authorized to survey the ionising radiation 
and radioactivity in the environment. It has to organise a yearly monitoring programme. Part 
of this programme is the survey of the consumption of radiopharmaceuticals from hospitals 
and their discharge to the environment. The basic data are delivered by the hospitals (yearly 
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consumption of radiopharmaceuticals and the discharge of total activity in 131I–equivalents to 
the rivers). Several Swiss WWTPs and waste incineration plants, which are in the catchment 
area of hospitals, chemical radionuclide producing industries and watch industries are moni-
tored continuously. Yearly, the BAG publishes the data [2].
4.2. Sampling
4.2.1. Water samples
For balancing radionuclides in waste water, a permanent sampling is necessary. This is only pos-
sible by using automatic water samplers. At the WWTP ProRheno, several samplers continuously 
collect water samples at several locations. Most important is the sampling of the untreated, raw 
waste water, before it enters the WWTP, and the treated waste water, before it is discharged to 
the Rhine River. The sampling rate of the samplers is fixed by the continuously recorded water 
flow rate. At higher rates, more water is sampled. Other samplers are necessary to control and 
optimise the waste water treatment processes inside the WWTP. At the waste incineration of 
Basel KVA Basel, the treated waste water from wet scrubbing of the flue gases is sampled perma-
nently over 24 hours a day. This sampling is not operated by the water flow rate. The monitoring 
programmes of WWTP ProRheno and the waste incineration plant KVA Basel are based on water 
samples, which are representative for the whole time period (24 hours or a week). The water 
samples are delivered once a week to the State Laboratory of Basel City. The cleaned waste 
water from WWTP ProRheno consists of a 1 L sample, which was sampled over a whole week. 
The cleaned waste water contains a small amount of insoluble material (20–40 mg/L). The water 
samples from KVA Basel are daily samples, which are mixed in the laboratory to get a week 
sample. These samples are free from insoluble materials. The water samples are filled into 1 L 
Marinelli beakers for gamma ray spectrometry.
4.2.2. Solid samples
For the balancing experiments at WWTP ProRheno, sewage sludge and ash samples have to be 
analysed. These samples are filled into cylindrical beakers of 500 mL volume or, where pos-
sible, into 1 L Marinelli beakers. Sewer samples (sewer sludge or sewer slime) are collected in 
the waste net of the city of Basel. The sewer is filled into petri dishes (6.5 cm Ø). Considering 
the short half-lives of the radionuclides of interest (e.g., 99mTc), the gamma ray counting has 
to be started immediately after having received the samples. All solid samples were counted 
without drying to take into account the short half-life of some radionuclides and the volatil-
ity of certain radionuclides (e.g., 131I). Afterwards, all solid samples were dried at 110°C. All 
activities were calculated back to a dry-weight basis.
In 1980–2012, suspended matter of the Rhine River was collected in 50 L barrels in three 
months periods upstream of the city of Basel. The suspended matter was then co-precipitated 
with potassium zinc hexacyanoferrate-(II), clarified using Carrez solutions, dried and anal-
ysed with gamma ray spectrometry. After 2002, the suspended matter from Rhine River was 
sampled once a month at the International Monitoring Station (Rüs) at Weil am Rhein, Germany, 
near Basel. To filter off the suspended matter from the water, a centrifuge was continuously 
loaded with Rhine water. This water was a mixture of the Rhine water over the whole pro-
file of the river. Depending on the water flow, the sampling time took one to several days. 
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The suspended matter was freeze-dried in the laboratory of the Office for Environmental 
Protection and Energy Basel City. The dried material was ground and filled into petri dishes 
(6.5 cm Ø and 4 cm height, volume: 77 mL) for gamma ray counting [11]. The counting time 
for suspended matter was 2–3 days.
4.3. Gamma ray spectrometry
The water samples are filled without filtration into 1 L Marinelli beakers and counted for 
24 hours with high resolution gamma ray spectrometers (Ge detectors). Different Ge detec-
tors from Ortec and Canberra are used at the State Laboratory of Basel City (25–50% relative 
efficiencies, all detectors are of coaxial type). For recording and analysis of the pulse high 
spectra, Maestro Dspec jr. from Ortec combined with Interwinner-software from ITEC is 
used. Regularly, all detectors are recalibrated with calibration sources from Czech Metrology 
Institute at Prague (mixtures of 241Am and 152Eu). All spectra are background subtracted. For 
water samples, no density correction is necessary because of the same density of the calibra-
tion sources (d = 1.0). Solid samples are corrected according to their density and composition. 
No summation corrections are done. Experimental details are described in [12]. For the iden-
tification and quantification of the most important radionuclides, the following emission lines 
(with emission probability in %) are used: 131I: 284.3 keV (6.2), 364.5 keV (81.6) and 637.0 keV 
(7.1), 177Lu: 112.95 keV (6.4) and 208.4 keV (11.0), 177mLu: 208.4 keV (62.2), 228.4 keV (37.8) and 
378.5 keV (28.3), 111In: 171.3 keV (90.2) and 245.4 keV (94.0), 186Re: 63.0 keV (1.9) and 137.2 keV 
(9.4), 99mTc: 140.5 keV (89.0), 153Sm: 69.7 keV (5.3) and 103.2 keV (28.3), 67Ga: 93.3 keV (39.0), 
184.6 keV (21.3), 300.2 keV (16.8) and 393.5 keV (4.6), 110mAg: 657.8 keV (94.4), 763.9 keV (22.5), 
884.7 keV (72.2) and 937.5 keV (34.3) and 223Ra: 81.1 keV (14.9), 83.8 keV (24.5) and 94.9 keV (8.5).
4.4. Beta ray spectrometry
Radionuclides, such as 90Y, are pure beta-emitters. Therefore, pre-treatment is necessary before 
a sample can be analysed with beta-spectrometry. Hospitals usually convert these activities 
into 131I–equivalent values. For a specific analysis of 90Y, samples of 50–100 mL are prepared 
as follows. First, the 90Y is co-precipitated with oxalic acid in the presence of a non-active 
Y-carrier (Y
3
Cl). The precipitates are isolated and ashed at 850°C. They are then dissolved in 
HCl and precipitated again at a pH of 5. 40K and most of the alkaline earth metals are isolated 
in this step. The 90Y is then precipitated in a strong alkaline medium as Y
2
Ox
3
. The decay of 90Y 
in these pure beta-sources is measured in 10 consecutive runs of 400 minutes each by means 
of a gas proportional counter (LB 4000 from Canberra). Beta-background and relative efficien-
cies of the beta-detectors (30–40%) have to be considered. The beta-efficiencies of the detectors 
are regularly tested using own 90Sr/90Y oxalate sources [13].
5. Results
5.1. The waste water monitoring at WWTP ProRheno
In 1997, a monitoring programme for cleaned waste water was started in Basel. This treated 
waste water is analysed on a weekly basis for 3H and gamma-active radiopharmaceuticals. In 
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1998, higher activities for 131I near the limit value were noted. The activity limit of 5 Bq/L was 
not crossed, but the discharge activity of 12 GBq exceeded by far the limit of 50 kBq for 131I. In 
that year, four violations were noted. Three of the four violations were due to discharges of 
waste water from the University Hospital. The reasons for the violations were diverse: over-
filling of waste water storage tanks, emptying of a wrong tank and technical problems with 
tank filling indication devices at the University Hospital. The State Laboratory Basel City 
started disciplinary proceedings against the responsible personnel [14]. The fourth violation 
was caused by the waste incineration plant of KVA Basel. At that time, the WWT at KVA Basel 
was stopped for revision works and the uncleaned waste water of the wet scrubbing was redi-
rected for treatment to the WWTP ProRheno. This fourth violation demonstrated that radioac-
tive contaminated wastes are also disposed of at KVA Basel.
Since 1999, no more violations of the limit values (e.g., 5 Bq/L for 131I, see Table 2) have 
been noted. In 2005, first activities of 111In were detected in the treated waste water of the 
city. In 2003, the University Hospital of Basel started applications of 177Lu, which were 
growing over the years. This can clearly be seen in Figure 3. Besides 177Lu, 131I and 111In, 
other radionuclides are detected sporadically, such as 188Re, 67Ga, 153Sm and 99mTc (Table 3). 
Radionuclides with very short half-lives, such as 99mTc or 18F, normally are not detected in 
the waste water [15].
At the hospitals, only a part of the applied radioactivity is released to the waste net. A non 
negligible amount of radioactive wastes is released at homes. Here, all treated patients remain 
emission sources for the following weeks. In Section 5.3, we present measurements in the 
waste net that clearly show this fact. Most of the patients treated at the local hospitals live in 
the vicinity of Basel. Their wastes are also treated at ProRheno and at KVA Basel.
5.2. Waste water monitoring at the incineration plant KVA Basel
Originally, the monitoring programme of cleaned waste water from wet scrubbing of flue 
gases was focused on the survey of the beta-nuclide 3H (tritium). From time to time, viola-
tions of the limits occurred, but no polluter could be identified. In 2001, the monitoring 
was extended for the survey of radiopharmaceuticals. To date, 131I is the only radionuclide 
that caused several violations of the limit values. In April 2008, a violation of both limits 
for 131I was noted. The activity of the effluent was 30 Bq/L and the discharge was calculated 
to be 15 MBq/month; both values were clearly over the limit [16]. In May 2014, a further 
violation of 131I was noted. The mean activity then was 24 Bq/L (limit value: 5 Bq/L) and 
the discharge was 6.4 MBq per month (limit: 50 kBq/month) [17]. In both cases, no specific 
polluter could be found. We suppose that the 131I–containing wastes were delivered by 
the local hospitals. Other radiopharmaceuticals were only detected sporadically (Figure 4, 
Table 4). Without specific indications, it is almost impossible to find a polluter. KVA 
Basel has to deal with over 500 waste deliveries per day. In 2018, according to the revised 
Radioprotection Ordinance, waste incineration plants are obliged to install a gamma-
detecting portal where all wastes are monitored for gamma rays when delivered at the 
plant. Overall, the detected activities in the effluent of the waste incineration plant KVA 
Basel were of minor concern due to the low discharge volume of about 500 m3/day of waste 
water to Rhine River.
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5.3. Detection of radioactive contamination in the waste net
The investigation of waste water by taking random samples in a waste net does not lead to 
representative results. This can only be achieved by using automatic water samplers. The 
installation and use of such samplers in the waste net is a difficult task. Therefore, it is only 
Figure 3. Monitoring of the treated waste water of the WWTP ProRheno since 1997.
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realised for the monitoring of specific emissions sources, which are under suspicion to violate 
the law. Another approach is the monitoring of sewer sludge or sewer slime. Sewer sludge is 
called a biofilm that grows on the interface of the waste water and the concrete of the waste 
net. Algae, bacteria and fungi build this biofilm, which acts as an excellent sorbent surface for 
many contaminants, such as heavy metals, polycyclic aromatic hydrocarbons, organochlorine 
compounds etc. [18, 19]. Radionuclides too, are adsorbed on this biofilms. The substances stay 
adsorbed until they are washed away from the concrete walls together with the sewer sludge 
or, in the case of the radionuclides, they have disintegrated. Therefore, sewer sludge can serve 
as a memory of the load of the run through waste water (Figure 5) [20].
Table 5 shows impressively the discrepancy between random sampling of waste water and 
the sampling of sewer sludge, which memorizes contamination of the waste system for a 
certain time. Only at two positions, site B and E, were traces of 131I and 177Lu detectable in the 
waste water on the sampling day, whereas 131I and 177Lu were detectable in the sewer sludge 
of several sites above and below the emission source. These activities are the result from past 
discharges of radioactive waste water. The fact that even above the emission source, radio-
nuclides were detected shows that patients at home are also emission sources for a certain 
time [21]. The sampling of sewer sludge illustrates the contamination of the waste net over a 
certain time period (some days, depending on the half-life of the analysed radionuclide); but 
it is not representative enough for the calculation of loads or the release of radionuclides in 
the waste net. Sewer slime analyses can be very useful to look for specific emission sources in 
a waste net [20].
5.4. Balance of radiopharmaceuticals at WWTPs
In 2014, Rumpel analysed influents and effluents of the WWTP ProRheno for two time periods 
of a month [20]. During this time, 24 hour samples from the untreated waste water and the 
cleaned waste water were collected and analysed with gamma ray spectrometry. Samples 
were collected with automatic samplers at the entrance of the WWTP (untreated waste water) 
and before the cleaned waste water was discharged to the Rhine River (cleaned waste water). 
The accumulated sewage sludge was collected and analysed daily before it was burnt. The 
ashes were collected in containers for transportation to the landfill site. Samples were taken 
from each container (four samples a month). The activities of the discharges were calculated 
Radionuclide Activity range Number of positive samples Mean ± s.d.
131I <0.1–4.8 1015 0.3 ± 0.3
177Lu <0.5–5.2 605 0.6 ± 0.9
111In <0.1–0.6 97 0.2 ± 0.1
67Ga <0.3–8.4 48 0.5 ± 1.5
186Re <0.5–23 7 4.4 ± 7.8
153Sm <0.3–0.72 3 0.5 ± 0.2
All values in Bq/kg. s.d.: standard deviation.
Table 3. Overview of the waste water monitoring at WWTP ProRheno from 1999 to 2016.
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by multiplying the activities with the daily waste water and sewage sludge discharges. Table 6 
shows clearly the bad elimination of 131I. Only 14% are eliminated by the WWT process. Almost 
90% of the 131I is dissolved in the water, passes the WWT and is discharged to Rhine River. 
The 14%, which are taken out of the waste water are lost by the burning of the sewage sludge 
(the ashes are free of 131I). On the other hand, 42% of 177Lu was eliminated in the WWT. This 
is not surprising. It corresponds to the elimination rate of heavy metals. The eliminated part 
Figure 4. Monitoring of the cleaned effluent from wet scrubbing at the waste incineration plant KVA Basel since 2001.
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Radionuclide Activity range Number of positive samples Mean ± s.d.
131I <0.1–36 708 1.0 ± 2.8
111In <0.1–1.6 7 0.7 ± 0.6
177Lu <0.5–2.7 6 1.0 ± 0.8
153Sm <0.3–34 4 11 ± 13
110mAg <0.1–0.14 3 0.1 ± 0.03
186Re <0.5–9.6 2 5.4 ± 4.2
All values in Bq/kg. s.d.: standard deviation.
Table 4. Overview of the waste water monitoring at the waste incineration KVA Basel from 2001 to 2016.
Figure 5. Sewer sludge (left) and the sampling of it in the waste net (right).
Sample date: 21.10.2014 Waste water (Bq/L) Sewer sludge (Bq/kg d.w.)
Radionuclide analysed 131I 177Lu 131I 177Lu
Above University Hospital
Site A
Site B
<0.1
1.2
<0.3
<0.3
<1
564
32
<20
Below University Hospital
Site C
Site D
Site E
<0.1
<0.1
<0.1
<0.4
<0.4
4
<1
<1
115
282
<4
9.570
Table 5. Comparison of waste water and sewer sludge at the same places in the waste net above and below the emission 
source (university hospital Basel).
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remains in the ashes from the burning of the sewage sludge, where it disintegrates according 
to its half-life of 6.7 days [14].
For 131I, similar observations were reported by Rose. The investigations of six WWTP’s in USA 
showed that most of the 131I passed the WWTP’s with the treated waste water [22]. In Finland, 
most of the 131I (up to 94 Bq/L) was found in the water phase, whereas, in the sewage sludge, 
51Cr, 111In, 201/202Tl and other radionuclides were found. Also, sporadically other radionuclides 
from nuclear power stations were detectable, such as 58Co, 60Co, 110mAg, or 124Sb [23]. In Kurume 
City, Japan, four hospitals discharge their waste waters to the local WWTP. The main activities 
of radiopharmaceuticals were found in the waste water. About 1–4% of the applied activities of 
99mTc, 123I, 67Ga and 201Tl were detected in the WWTP. 131I was only found in the sewage sludge 
[24]. This is confirmed by others. Investigations in Canada, Italy, France and Sweden showed 
that the main activities were in the sewage sludge [25–28]. About 1–250 Bq/kg of 201Tl, 99mTc, 
131I were measured in the sewage sludge of French WWTPs [29]. In the WWTP of Valladolid, 
Spain, 75–1238 Bq/kg d.w. of 131I was found in sewage sludge [30]. Hormann and Fischer inves-
tigated the WWTP of Bremen-Seehausen in Germany. They found an overall elimination rate 
of 50–75% for 131I. Most of the 131I was bound to the sewage sludge. They concluded that 131I was 
bound to the return sludge and therefore a longer residence time of the waste water resulted. 
About 30% of the input was organically bound. After the cleaning processes, over 90% was 
organically bound and therefore could be eliminated from the waste water cycle [31].
Such discrepancies of the fate of radiopharmaceuticals in WWTPs can be explained as fol-
lows. The waste water treatment processes, which can vary from WWTP to WWTP, also have 
influence on the behaviour of the radiopharmaceuticals during the waste water cleaning pro-
cess. How radiopharmaceuticals are administered (inorganic unbound, or organically bound) 
is crucial for the elimination behaviour of radiopharmaceuticals in a WWTP.
5.5. Monitoring of suspended matter of Rhine River at Basel
Since 1982, the suspended matter of Rhine River is collected periodically and analysed for 
radio contamination. This is part of the monitoring programmes of the BAG for the survey of 
Swiss Nuclear Power Plants (NPP) and WWTPs. From 1982 to 2002, suspended matter was 
collected in three month periods upstream of the city of Basel. Since 2002, suspended matter 
was collected monthly by means of a centrifuge at the river monitoring station Weil am Rhein 
downstream of the city.
In 1982 and 1986, high activities of 131I were found in suspended matter of Rhine River. In 
1982, the NPP of Mühleberg discharged radioactive water to Aar River, which is connected 
Radionuclide
MBq/m3
Untreated waste 
water
Treated waste 
water
Sewage 
sludge
Ash from sewage 
sludge
Elimination rate %
131I 812 701 52 0.2 ~14
177Lu 5.500 3.207 1.628 856 ~42
Table 6. Balance of radionuclides in the WWTP ProRheno.
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to Rhine River [32]. As a consequence, in 1982, the suspended matter contained 14.8 Bq/kg of 
131I and 88 Bq/kg of 137Cs. Additionally, some activation products typically found in emissions 
from NPPs, such as 60Co (85 Bq/kg) and 54Mn (14.8 Bq/kg), could be detected [33].
In 1986, 2,580 ± 1,680 Bq/kg of 131I were found in the suspended matter of Rhine River, together 
with 1,720 ± 930 Bq/kg of 134Cs and 3,500 ± 1,740 Bq/kg of 137Cs. These high contaminations 
originated from the fallout of the reactor fire at Chernobyl in that year [34]. Only after 2006, 
a regular monitoring for short-lived radionuclides from pharmaceutical use was realised. 
When short-lived radionuclides have to be monitored, it is important to analyse the collected 
suspended matter as soon as possible. Before 2006, samples were collected over a year and 
analysed at the end of the year. Therefore, the short-lived radionuclides were already disinte-
grated. In suspended matter, the radionuclides 131I and 177Lu are prominent. Since 2009, they 
are detectable in almost every sample and reflect mainly the local emissions from the WWTP 
ProRheno (Figure 6, Table 7). In 2015 and 2016, the radionuclide 177mLu was found. We suppose 
Figure 6. Results from monitoring of suspended matter of Rhine River. All annual average values in Bq/kg dry weight.
Radionuclide Activity range Number of positive samples Mean ± s.d.
67Ga 0–59 7 30 ± 21
85Sr 0–83 21 25 ± 22
131I 0–258 94 5.8 ± 5.6
153Sm 0–183 6 105 ± 65
169Er 0–1,550 1 1,550
177Lu 0–390 92 82 ± 117
177mLu 0–3 4 3.0 ± 0.1
186Re 0–1,034 1 1,934
223Ra 0–33 8 16 ± 8.2
All values in Bq/kg dry weight.
Table 7. Development of yearly mean activities in suspended matter from 1982 to 2016.
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that this nuclide was applied instead of 177Lu, when there were supply difficulties for 177Lu. 
177mLu has a long half-life of 161 days and should therefore not be regularly used for pharma-
ceutical applications. It remains much longer in the environment, where it can cause dam-
age. Other radionuclides, such as 67Ga, 153Sm, or 85Sr, were found sporadically. Here, different 
sources (hospitals), connected to the Rhine River catchment, are possible. Since 2015, 223Ra can 
regularly be found in the suspended matter. Overall, over these years, there were observed 
no violation of the immission limits for rivers according to the Radioprotection Ordinance. 
These limits are defined for activities of the river water. In suspended matter, these radionu-
clides are highly enriched by the collection process of the suspended matter. Supposing a total 
adsorption of the radionuclides to the suspended particles, the enrichment factor is 1000 and 
more. Nevertheless, there is only poor knowledge about the low dose effects of radiation on 
aquatic organisms.
6. Conclusion
Our monitoring programmes for radiopharmaceuticals show that radioactivity is perma-
nently released to the environment despite rigorous treatment and cleaning of the radio-
active wastes from hospitals. The limits for radionuclides in rivers and lakes are observed. 
Nevertheless, little is known about the low dose effects of radiation on aquatic organisms, 
which may occur well below these limits. Overall, the permanent monitoring of radionuclides 
in the environment of cities remains an important task.
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